Shopping Cart
- Remove All
Your shopping cart is currently empty
GRKs-IN-1 hydrochloride, Compound 14as, has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50=130 nM) and GRK5 (IC50=7.1 μM).GRKs-IN-1 hydrochloride is a derivative 14as of paroxetine, shows a 100-fold improvement in cardiomyocyte contractility assays over paroxetine[1].
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $108 | Backorder | |
| 2 mg | $174 | Backorder | |
| 5 mg | $291 | Backorder | |
| 10 mg | $456 | Backorder | |
| 25 mg | $822 | Backorder | |
| 50 mg | $1,360 | Backorder | |
| 100 mg | $1,860 | Backorder | |
| 1 mL x 10 mM (in DMSO) | $312 | Backorder |
| Description | GRKs-IN-1 hydrochloride, Compound 14as, has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50=130 nM) and GRK5 (IC50=7.1 μM).GRKs-IN-1 hydrochloride is a derivative 14as of paroxetine, shows a 100-fold improvement in cardiomyocyte contractility assays over paroxetine[1]. |
| Targets&IC50 | GRK2:30 nM, GRK5:7.1 μM |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O: 50 mg/mL (102.26 mM), Sonication is recommended. DMSO: 250 mg/mL (511.31 mM), Sonication is recommended. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.